

Publisher: John Wiley & Sons Inc
E-ISSN: 1365-2036|47|3|449-450
ISSN: 0269-2813
Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.3, 2018-02, pp. : 449-450
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Proton‐Pump Inhibitor use and the risk of Ischaemic Stroke
JOURNAL OF INTERNAL MEDICINE, Vol. 283, Iss. 3, 2018-03 ,pp. :





